Since 2016, Atara Biotherapeutics has worked with Veeva to centralize regulatory data and documents, align cross-functional teams, and automate manual processes. As the biotech company continues to grow, Veeva Vault RIM is evolving with them to help keep pace in a rapidly changing environment.
Accelerating the Delivery of Business Value
In early 2020, Atara kicked off an initiative to better prepare its regulatory organization for the future. The company was underutilizing Vault RIM, so it launched an optimization program to maximize the solution’s existing value while also adding new capabilities to prepare for anticipated growth. Atara focused its efforts on improving Vault Submissions, adopting Vault Registrations for registration tracking, and rolling out Vault Submissions Publishing to support in-house publishing of upcoming marketing applications.
In parallel, Atara overhauled its system implementation practices to streamline validation efforts and bring new functionality to users. The company adopted an agile, risk-based approach to validating new functionality that allowed for more frequent, incremental upgrades and improved user adoption. These methodology updates continue to accelerate the deployment of Atara’s configuration changes along with innovations in Vault RIM’s regular release cycles.
Capabilities Continue to Evolve and Expand
The unified Vault RIM solution is fast becoming a strategic asset to Atara, and will continue to evolve as the company prepares for commercialization. They now have access to information that’s connected and readily available in an authoritative system, which supports faster, more effective decisions. As a result, Atara staff are starting to see improvements in operational processes and in the quality of their work products.
“A RIM system starts to become a strategic asset for organizations that do it right.” – Matt Neal, Senior Director Regulatory Affairs Operations, Atara Biotherapeutics